The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, mentorship, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

Novel Coronavirus / COVID-19 Resources

The INS Peer-Reviewed Journal

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online. The journal also has social media accounts on Twitter, Facebook, and Instagram.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Regulatory Classification Posted for Surgical-Planning Software Recall

June 1, 2020 - A notice on the FDA website identifies as Class 1 Medtronic's Aug. 9, 2019 recall of an auto-registration feature of its  Cranial software version 3.0 or newer (3.0, 3.1, 3.1.1) with StealthStation DBS License or StealthStation S8 Software with Stealth DBS License. The software was distributed from Feb. 1, 2026 to May 1, 2019, and 54 consignees were notified. (Source: Medscape)

Registry Outcomes of Intrathecal Ziconotide for Chronic Pain Reported

May 29, 2020 - A publication presents an analysis of results of a registry, which was an open-label, long-term, mulitcenter observational study, that evaluated the short- and long-term safety and effectiveness of intrathecal ziconotide based on patient-reported outcomes. (Source: Pain Medicine)

Authors Raise the Potential of Neuromodulation of Inflammatory Response in COVID-19-Related Organ Dysfunction

May 26, 2020 - A multidisciplinary group of authors from Duke University has published a journal article on "Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19." The authors describe the potential for multiorgan failure from inflammatory cytokines and the potential for reversing inflammation through vagus nerve stimulation. They add that a human study into influencing the inflammatory reflex through splenic nerve stimulation has begun (sponsored by Galvani Bioelectronics). (Source: Journal of Cardiovascular Translational Research)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs

International Neuromodulation Society 3rd Interim Meeting, Oct. 23-25, 2020, Mumbai, India:

Last Updated on Monday, December 12, 2016 10:01 AM